MYM Nutraceuticals Inc (CNSX:MYM) Again Leads Rudderless Cannabis Market

Benjamin A. Smith

MYM Nutraceuticals Inc (CNSX:MYM) (OTCMKTS: MYMMF) lead the cannabis sector’s uninspiring aggregate gains today—this time by default. Aside from select small cap names, the market has ground to a standstill, in what can only be described as a “dull” and “lifeless” market.

There were pockets of life below the $500 million market cap threshold, however. Yesterday’s big winner MYM Nutraceuticals again paced the top performers list, jumping $0.18 to $1.58/share (↑12.86%). The bulk of gains were realized from a powerful morning continuation gap, to a short-term price objective we predicted yesterday. The action in MYM is likely the impetus for much of the short covering/bottom picking materializing in the small cap sector, as sellers scurry away from the ask en masse.

Another notable winner was Cannex Capital Holdings. Shares in the Washington State LP and edibles leader climbed $0.10 to $1.20/share (↑9.09%). The interesting aspect to today’s trade is the volume profile, which exploded around midday and carried aggregate volume to its highest point in almost a month. The cause appears to be technical buying above the recent channel, as no news surfaced to account for the move.

We recently highlighted Cannex’s business profile, as they attempt to extend the Washington cannabis dominance to California.

Cannex Capital CEO Anthony Dutton outlines the company’s plans in regard to transplanting their leadership position in Washington State onto California.

Rounding out the Top 5 percentage gainers were an array of beaten-down small cap issues. Volume generally trended above average in these names, in dichotomy to its mid/large cap peers.

Company Last Change % Change Volume
MYM Nutraceuticals Inc 1.58 0.18 12.86% 5.74m
Maricann Group Inc. 1.74 0.17 10.83% 1.40m
Hiku Brands Company Ltd. 1.65 0.16 10.74% 793.63k
Namaste Technologies Inc. 1.5 0.14 10.29% 4.52m
Abcann Global Corporation 1.51 0.13 9.42% 855.50k

Various Knickknacks From Around The Sector

– Excluding the TSX Exchange failure, which halted trading for most of the afternoon on April 27, Canopy Growth Corp. registered its volume day since October 26, 2017. Only 1,380,550 shares traded hands today, besting the 987,620 shares traded 6.5 months ago.

– At 2,950,128 shares, Aurora Cannabis Inc. also finished with its lowest volume since November 2, 2107. This includes the TSX outage day of April 27, and is roughly 70% lower than its 3-month average.

CannaRoyalty Corp. experienced a strong intraday rebound off morning weakness. After falling almost nine percent, peak-to-trough, the burgeoning California operator (profiled here) pared losses. For the day, CannaRoyalty lost $0.14 to $4.73/share (↓2.87%), leaving its strong technical picture intact.

It appears market participants decided to “shake the tree” and pry loose shares from some weak hands. Judging by the non-existent spike in volume profile near the day’s lows, the maneuver wasn’t apparently successful.

Benjamin A. Smith

Benjamin A. Smith

Ben is a research analyst and capital markets professional with nearly 20 years of experience. His areas of expertise are broad-based, and include extensive knowledge of macro economics, stock/derivative trading, commodity complexes, cryptocurrencies and technical/quant analysis. He also maintains an particular affinity for U.S. politics and the macro-regulatory environment facing...
More Info...

[email protected] |

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!